Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial metal-dependent enzymes and metalloproteins represent a diverse and essential class of proteins in bacteria, fungi, and protozoa that utilize metal ions—such as zinc, iron, manganese, and nickel—as cofactors for catalytic activity or structural stability (Frontiers in Pharmacology, 2021). These proteins are involved in a wide array of fundamental biological processes, including DNA synthesis, metabolic pathways, and the neutralization of reactive oxygen species (MDPI, 2024). In pathogenic microbes, metalloenzymes often function as critical virulence factors or mediate resistance to conventional antibiotics, exemplified by the zinc-dependent metallo-beta-lactamases (e.g., NDM-1) that confer resistance to carbapenems (ACS Chemical Reviews, 2018). Therapeutic strategies targeting this class include the use of small-molecule inhibitors that coordinate with the active-site metal, metal chelators that disrupt metal homeostasis, and siderophore-drug conjugates that exploit microbial metal acquisition systems (NIH, 2024). However, a significant challenge in drug development is achieving selectivity to avoid off-target inhibition of essential human metalloenzymes, such as matrix metalloproteinases or carbonic anhydrases (Frontiers in Chemistry, 2021).
Inhibition of catalytic activity through active-site metal coordination, competitive inhibition, metal chelation, or exploitation of metal transport systems (e.g., siderophore-drug conjugates).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial metal-dependent enzymes and metalloproteins.